Epigenetic changes of DNA repair genes in cancer

C Lahtz, GP Pfeifer - Journal of molecular cell biology, 2011 - academic.oup.com
Abstract 'Every Hour Hurts, The Last One Kills'. That is an old saying about getting old. Every
day, thousands of DNA damaging events take place in each cell of our body, but efficient …

Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma

H Tsuyoshi, Y Yoshida - Cancer science, 2018 - Wiley Online Library
Uterine leiomyosarcoma (u‐LMS) and endometrial stromal sarcoma (ESS) are among the
most frequent soft tissue sarcomas, which, in adults, lead to fatal lung metastases and …

Ovarian cancer progression is controlled by phenotypic changes in dendritic cells

UK Scarlett, MR Rutkowski, AM Rauwerdink… - Journal of Experimental …, 2012 - rupress.org
We characterized the initiation and evolution of the immune response against a new
inducible p53-dependent model of aggressive ovarian carcinoma that recapitulates the …

Genomic landscape of uterine sarcomas defined through prospective clinical sequencing

ML Hensley, SS Chavan, DB Solit, R Murali… - Clinical Cancer …, 2020 - AACR
Purpose: We examined whether prospective molecular characterization of advanced
metastatic disease can reveal grade and/or histology-specific differences to inform diagnosis …

Epigenetic regulation of DNA repair genes and implications for tumor therapy

M Christmann, B Kaina - Mutation Research/Reviews in Mutation Research, 2019 - Elsevier
DNA repair represents the first barrier against genotoxic stress causing metabolic changes,
inflammation and cancer. Besides its role in preventing cancer, DNA repair needs also to be …

BRCA1/2 Functional Loss Defines a Targetable Subset in Leiomyosarcoma

ND Seligson, EA Kautto, EN Passen, C Stets… - The …, 2019 - academic.oup.com
Background Soft‐tissue sarcomas (STS) describe a heterogeneous group of mesenchymal
tumors with limited treatment options. Targeted therapies exist for BRCA1/2 gene alterations …

[HTML][HTML] The biology of uterine sarcomas: a review and update

H Kobayashi, C Uekuri, J Akasaka… - Molecular and …, 2013 - spandidos-publications.com
Uterine sarcoma is a rare neoplasm, accounting for only 5% of uterine malignancies. The
pathogenesis of uterine sarcoma remains largely unknown, although recent basic science …

BRCA1 Loss Preexisting in Small Subpopulations of Prostate Cancer Is Associated with Advanced Disease and Metastatic Spread to Lymph Nodes and Peripheral …

N Bednarz, E Eltze, A Semjonow, M Rink… - Clinical Cancer …, 2010 - AACR
Purpose: A preliminary study performed on a small cohort of multifocal prostate cancer
(PCa) detected BRCA1 allelic imbalances among circulating tumor cells (CTC). The present …

Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo

LK Mullany, HY Fan, Z Liu, LD White, A Marshall… - Oncogene, 2011 - nature.com
Ovarian cancer is a complex and deadly disease that remains difficult to detect at an early
curable stage. Furthermore, although some oncogenic (Kras, Pten/PI3K and Trp53) …

A small-molecule inhibitor targeting the mitotic spindle checkpoint impairs the growth of uterine leiomyosarcoma

W Shan, PY Akinfenwa, KB Savannah… - Clinical Cancer …, 2012 - AACR
Purpose: Uterine leiomyosarcoma (ULMS) is a poorly understood cancer with few effective
treatments. This study explores the molecular events involved in ULMS with the goal of …